Table I Index
Table of Contents
Table I - 2 Allen Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 1,126 | 332.2 | 529 | 366.6 | 597 | 310.0 |
Oral cavity and pharynx | 21 | 6.4 | 16 | 10.7** | 5 | 3.1** |
Lip | * | # | * | # | * | # |
Tongue | * | # | * | # | * | # |
Major salivary glands | 5 | 1.5** | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | * | # | * | # | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 223 | 63.9 | 114 | 78.8 | 109 | 52.3 |
Esophagus | 16 | 4.5** | 12 | 8.0** | * | # |
Stomach | 8 | 2.3** | 5 | 3.7** | * | # |
Small intestine | 6 | 1.7** | * | # | * | # |
Colon excluding rectum | 114 | 31.8 | 53 | 36.7 | 61 | 27.9 |
Rectum and rectosigmoid | 44 | 12.8 | 24 | 16.8 | 20 | 9.8 |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | * | # | * | # | * | # |
Gallbladder | * | # | * | # | * | # |
Other biliary | * | # | * | # | * | # |
Pancreas | 22 | 6.7 | 12 | 8.0** | 10 | 5.7** |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 181 | 55.6 | 111 | 78.8 | 70 | 37.3 |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | 16 | 5.1** | 15 | 10.6** | * | # |
Lung and bronchus | 160 | 48.8 | 92 | 65.2 | 68 | 36.0 |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | 8 | 2.5** | 5 | 3.0** | * | # |
Skin (excluding basal and squamous) | 22 | 6.2 | 11 | 7.1** | 11 | 5.9** |
Melanoma of the skin | 16 | 4.5** | 7 | 4.6** | 9 | 4.7** |
Other non-epithelial skin cancers | 6 | 1.8** | * | # | * | # |
Breast | 192 | 54.7 | * | # | 190 | 98.1 |
Female genital system | 104 | 31.0 | -- | -- | 104 | 57.5 |
Cervix uteri | 22 | 6.0 | -- | -- | 22 | 11.5 |
Corpus uteri | 46 | 14.0 | -- | -- | 46 | 25.7 |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | 29 | 9.0 | -- | -- | 29 | 16.9 |
Vagina | * | # | -- | -- | * | # |
Vulva | 5 | 1.5** | -- | -- | 5 | 2.5** |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 126 | 38.4 | 126 | 88.6 | -- | -- |
Prostate gland | 122 | 37.5 | 122 | 86.7 | -- | -- |
Testis | * | # | * | # | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 99 | 28.0 | 68 | 45.4 | 31 | 14.5 |
Urinary bladder | 51 | 14.4 | 39 | 26.7 | 12 | 5.5** |
Kidney and renal pelvis | 41 | 11.9 | 25 | 16.1 | 16 | 8.2** |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | 22 | 6.7 | 13 | 9.1** | 9 | 4.5** |
Brain | 22 | 6.7 | 13 | 9.1** | 9 | 4.5** |
Other nervous system | * | # | * | # | * | # |
Endocrine system | 19 | 5.3** | 5 | 3.1** | 14 | 7.5** |
Thyroid gland | 18 | 5.0** | * | # | 14 | 7.5** |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 50 | 15.6 | 25 | 17.5 | 25 | 13.5 |
Hodgkin’s disease | 8 | 2.7** | * | # | * | # |
Non-Hodgkin’s lymphoma | 42 | 12.9 | 21 | 14.4 | 21 | 11.3 |
Multiple myeloma | 8 | 2.4** | * | # | * | # |
Leukemia | 20 | 6.5 | 14 | 10.3** | 6 | 2.9** |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | * | # | * | # | * | # |
Acute myeloid | 10 | 3.2** | 6 | 4.7** | * | # |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | * | # | * | # | * | # |
Other, ill-defined and unknown sites | 27 | 7.7 | 12 | 7.8** | 15 | 8.0** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
Table I Index
Table of Contents